Is adjunctive open-label zonisamide effective for bipolar disorder?

Journal of Affective Disorders

Volumn 105, Issue 1-3, 2008, Pages 311-314

  Ghaemi, S Nassir ^a   Shirzadi, Arshia A ^b   Klugman, Jeffry ^c   Berv, Douglas A ^c   Pardo, Tamara B ^d   Filkowski, Megan M ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Atlantic Health Services   (United States)

^d Bipolar Disorder Research Program   (United States)

Author keywords

Bipolar disorder; Depression; Drug therapy; Mania; Mood disorders; Zonisamide

Indexed keywords

ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; VALPROIC ACID; ZIPRASIDONE; ZONISAMIDE;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG EMBOLISM; MALE; NAUSEA; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; TREATMENT INDICATION; TREATMENT RESPONSE; VISUAL HALLUCINATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 37049031044     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.05.011     Document Type: Article

References (13)

1. Anand A., Bukhari L., Jennings S.A., Lee C., Kamat M., Shekhar A., Nurnberger Jr. J.I., and Lightfoot J. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. J. Clin. Psychiatry 66 (2005) 195-198
2. Baldassano C.F., Ghaemi S.N., Chang A., Lyman A., and Lipari M. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review. Bipolar Disord. 6 (2004) 432-434
3. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., Cutler A.J., Mccoy R., Wilson E., and Mullen J. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 162 (2005) 1351-1360
4. Ghaemi S.N., and Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers?. Harv. Rev. Psychiatry 8 (2000) 1-7
5. Ghaemi S.N., Hsu D.J., Soldani F., and Goodwin F.K. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 5 (2003) 421-433
6. Goodwin F., and Jamison K. Manic Depressive Illness (1990), Oxford University Press, New York
7. Kanba S., Yagi G., Kamijima K., Suzuki T., Tajima O., Otaki J., Arata E., Koshikawa H., Nibuya M., Kinoshita N., et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 18 (1994) 707-715
8. Mcelroy S.L., Suppes T., Keck Jr. P.E., Black D., Frye M.A., Altshuler L.L., Nolen W.A., Kupka R.W., Leverich G.S., Walden J., Grunze H., and Post R.M. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J. Clin. Psychiatry 66 (2005) 617-624
9. Moller H.J., Grunze H., and Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 1-16
10. Oommen K.J., and Mathews S. Zonisamide: a new antiepileptic drug. Clin. Neuropharmacol. 22 (1999) 192-200
11. Rothman K., and Greenland S. Modern epidemiology (1998), Lippincott-Raven, Philadelphia, PA
12. Sanger T.M., Grundy S.L., Gibson P.J., Namjoshi M.A., Greaney M.G., and Tohen M.F. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J. Clin. Psychiatry 62 (2001) 273-281
13. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., Tollefson G.D., and Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry 60 (2003) 1079-1088